Jayadeep Patra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jayadeep Patra has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Jürgen Rehm
Institute for Mental Health Policy Research Centre for Addiction and Mental Health Toronto Canada
10 shared publications - Svetlana Popova
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON M5S 2S1, Canada
7 shared publications Jürgen Rehm
5 shared publications- Dolly Baliunas
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
4 shared publications - Kevin David Shield
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
4 shared publications - Benedikt Fischer
Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada
3 shared publications
Latest Publications
- 14 May 2025
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 60 (4)
Trends in economic indicators, alcohol use, and alcohol-attributable health indicators in India
Aims: Economic development leading a country from a low- to middle-income status is usually associated with increases in alcohol consumption and decreases in all-cause mortality, despite increases in alcohol-attributable mortality. We analyzed this tradition for India during the years 2000–19, with attention to alcohol policy. Methods: Joinpoint analysis identified points of trend change and associated slopes for alcohol-attributable mortality and burden (disability-adjusted life years) between 2000 and 2019. Structural equation modeling assessed the relationship among adult alcohol per capita consumption, gross domestic product per capita at purchasing power parity (GDP-PPP per capita), alcohol-attributable mortality, and all-cause mortality, where mortality rates were log-transformed in the models. Pearson correlation was evaluated among study variables. Literature review examined alcohol policies in India. Results: During the first decade between 2000 and 2019, a rapidly and steadily increasing GDP-PPP per capita was associated with marked increases in alcohol consumption and decreases in all-cause mortality, despite increasing alcohol-attributable mortality. After 2010, the economic growth still increased, but the increase in alcohol consumption halted, likely due to strong alcohol control policies in availability restrictions (dry states, dry periods, high legal purchasing age and restrictions in density, and purchasing hours), as well as a high tax share on final price. Conclusion: Alcohol policies seem to have prevented further increases in alcohol consumption and attributable harm and thus should be upheld. Otherwise, increases in these harms will prevent India from fully reaping the health benefits of economic development.
- 14 May 2025
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 60 (4)
Trends in economic indicators, alcohol use, and alcohol-attributable health indicators in India
Aims: Economic development leading a country from a low- to middle-income status is usually associated with increases in alcohol consumption and decreases in all-cause mortality, despite increases in alcohol-attributable mortality. We analyzed this tradition for India during the years 2000–19, with attention to alcohol policy. Methods: Joinpoint analysis identified points of trend change and associated slopes for alcohol-attributable mortality and burden (disability-adjusted life years) between 2000 and 2019. Structural equation modeling assessed the relationship among adult alcohol per capita consumption, gross domestic product per capita at purchasing power parity (GDP-PPP per capita), alcohol-attributable mortality, and all-cause mortality, where mortality rates were log-transformed in the models. Pearson correlation was evaluated among study variables. Literature review examined alcohol policies in India. Results: During the first decade between 2000 and 2019, a rapidly and steadily increasing GDP-PPP per capita was associated with marked increases in alcohol consumption and decreases in all-cause mortality, despite increasing alcohol-attributable mortality. After 2010, the economic growth still increased, but the increase in alcohol consumption halted, likely due to strong alcohol control policies in availability restrictions (dry states, dry periods, high legal purchasing age and restrictions in density, and purchasing hours), as well as a high tax share on final price. Conclusion: Alcohol policies seem to have prevented further increases in alcohol consumption and attributable harm and thus should be upheld. Otherwise, increases in these harms will prevent India from fully reaping the health benefits of economic development.
- Open Access
- 29 January 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (1) , e0003754
Treatment outcomes among children and adolescents with extensively drug–resistant (XDR) and pre–XDR tuberculosis: Systematic review and meta–analysis
Extensively drug–resistant (XDR) and pre-XDR- tuberculosis (TB) account for approximately a third of pediatric MDR–TB cases globally. Clinical management is challenging; recommendations are based on limited evidence. We assessed the clinical outcomes for children and adolescents treated for XDR–and pre–XDR–TB. We performed a systematic review and meta–analysis of published studies reporting treatment outcomes for children and adolescents with XDR–and pre–XDR–TB. MEDLINE, EMBASE, Scopus, Web of Science, Google Scholar, and trial registries up to 31 December 2023 were searched. Eligible studies included children and adolescents aged <18 years with XDR–or pre–XDR–TB. The primary outcome was treatment success, defined as a composite of cure and treatment completion. Secondary outcomes were death, failure/ lost to follow–up and adverse events. We identified 34 population-based studies and 14 case studies, which reported treatment outcomes for a total of 656 patients. Treatment durations ranged from 6 to 27 months; follow–up after treatment completion ranged from 2 months to 4 years. The pooled estimate for treatment success in XDR–and pre-XDR-TB was 88·9% (95%CI: 59·7–100%) and 65·4% (95%CI: 27·7–100%), respectively. Drug adverse effects were reported in 56.4% (95%CI: 9.9–100%) and 68.2% (95%CI: 0–100%) of children respectively. Few childhood XDR- and pre-XDR-TB cases are reported. The relatively good treatment outcomes in children compared to adults may be partly due to publishing bias. Drug adverse effects are common.
- 29 January 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (1) , e0003754
Open AccessTreatment outcomes among children and adolescents with extensively drug–resistant (XDR) and pre–XDR tuberculosis: Systematic review and meta–analysis
Extensively drug–resistant (XDR) and pre-XDR- tuberculosis (TB) account for approximately a third of pediatric MDR–TB cases globally. Clinical management is challenging; recommendations are based on limited evidence. We assessed the clinical outcomes for children and adolescents treated for XDR–and pre–XDR–TB. We performed a systematic review and meta–analysis of published studies reporting treatment outcomes for children and adolescents with XDR–and pre–XDR–TB. MEDLINE, EMBASE, Scopus, Web of Science, Google Scholar, and trial registries up to 31 December 2023 were searched. Eligible studies included children and adolescents aged <18 years with XDR–or pre–XDR–TB. The primary outcome was treatment success, defined as a composite of cure and treatment completion. Secondary outcomes were death, failure/ lost to follow–up and adverse events. We identified 34 population-based studies and 14 case studies, which reported treatment outcomes for a total of 656 patients. Treatment durations ranged from 6 to 27 months; follow–up after treatment completion ranged from 2 months to 4 years. The pooled estimate for treatment success in XDR–and pre-XDR-TB was 88·9% (95%CI: 59·7–100%) and 65·4% (95%CI: 27·7–100%), respectively. Drug adverse effects were reported in 56.4% (95%CI: 9.9–100%) and 68.2% (95%CI: 0–100%) of children respectively. Few childhood XDR- and pre-XDR-TB cases are reported. The relatively good treatment outcomes in children compared to adults may be partly due to publishing bias. Drug adverse effects are common.
- Open Access
- 30 March 2021
- Published by Wiley in Drug and Alcohol Review
- Vol. 40 (7) , 1377-1386
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification
Issues: Alcohol use has been shown to impact on various forms of liver disease, not restricted to alcoholic liver disease.Approach: We developed a conceptual framework based on a narrative review of the literature to identify causal associations between alcohol use and various forms of liver disease including the complex interactions of alcohol with other major risk factors. Based on this framework, we estimate the identified relations for 2017 for the USA.Key Findings: The following pathways were identified and modelled for the USA for the year 2017. Alcohol use caused 35 200 (95% uncertainty interval 32 800–37 800) incident cases of alcoholic liver cirrhosis. There were 1700 (uncertainty interval 1100–2500) acute hepatitis B and C virus (HBV and HCV) infections attributable to heavy‐drinking occasions, and 14 000 (uncertainty interval 5900–19 500) chronic HBV and 1700 (uncertainty interval 700–2400) chronic HCV infections due to heavy alcohol use interfering with spontaneous clearance. Alcohol use and its interactions with other risk factors (HBV, HCV, obesity) led to 54 500 (uncertainty interval 50 900–58 400) new cases of liver cirrhosis. In addition, alcohol use caused 6600 (uncertainty interval 4200–9300) liver cancer deaths and 40 700 (uncertainty interval 36 600–44 600) liver cirrhosis deaths.Implications: Alcohol use causes a substantial number of incident cases and deaths from chronic liver disease, often in interaction with other risk factors.Conclusion: This additional disease burden is not reflected in the current alcoholic liver disease categories. Clinical work and prevention policies need to take this into consideration.
- 30 March 2021
- Published by Wiley in Drug and Alcohol Review
- Vol. 40 (7) , 1377-1386
Open AccessThe role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification
Issues: Alcohol use has been shown to impact on various forms of liver disease, not restricted to alcoholic liver disease.Approach: We developed a conceptual framework based on a narrative review of the literature to identify causal associations between alcohol use and various forms of liver disease including the complex interactions of alcohol with other major risk factors. Based on this framework, we estimate the identified relations for 2017 for the USA.Key Findings: The following pathways were identified and modelled for the USA for the year 2017. Alcohol use caused 35 200 (95% uncertainty interval 32 800–37 800) incident cases of alcoholic liver cirrhosis. There were 1700 (uncertainty interval 1100–2500) acute hepatitis B and C virus (HBV and HCV) infections attributable to heavy‐drinking occasions, and 14 000 (uncertainty interval 5900–19 500) chronic HBV and 1700 (uncertainty interval 700–2400) chronic HCV infections due to heavy alcohol use interfering with spontaneous clearance. Alcohol use and its interactions with other risk factors (HBV, HCV, obesity) led to 54 500 (uncertainty interval 50 900–58 400) new cases of liver cirrhosis. In addition, alcohol use caused 6600 (uncertainty interval 4200–9300) liver cancer deaths and 40 700 (uncertainty interval 36 600–44 600) liver cirrhosis deaths.Implications: Alcohol use causes a substantial number of incident cases and deaths from chronic liver disease, often in interaction with other risk factors.Conclusion: This additional disease burden is not reflected in the current alcoholic liver disease categories. Clinical work and prevention policies need to take this into consideration.
- 8 March 2021
- Published by Wiley in Drug and Alcohol Review
- Vol. 40 (6) , 1061-1070
Impact of body mass and alcohol consumption on all‐cause and liver mortality in 240 000 adults in the United States
Introduction: Nationally representative studies of the combined impact of drinking and body mass (BMI) on mortality outcomes are unavailable. We investigate whether both act together to elevate risk of all‐cause or liver mortality.Methods: We obtained self‐reported histories of drinking and BMI from 129 098 women (mean age 47.2 years) and 102 568 men (mean age 45.6 years) ≥18 years interviewed from 1997 to 2004 in the National Health Interview Survey and related these data to the deaths that occurred by 31 December 2006 (women = 8486; men = 7819 deaths). Death hazards among current drinkers in different BMI groups were adjusted for age, education, race and smoking.Results: Obese (≥30 kg m−2) adults with consumption of >40 g day−1 (women) or >60 g day−1 (men) pure ethanol were at risk of increased mortality from all‐cause and chronic liver disease (P trend −2, each 5 kg m−2 higher BMI was associated with an elevated all‐cause mortality in men (hazard ratios 1.27, 95% confidence interval [CI]: 1.16–1.40) and women (1.12, [1.02–1.24]). The excess risk due to interaction was more pronounced in men (7.30, [3.60–11.00]) than women (2.90, [0.50–5.30]).Discussion and Conclusions: Obesity and excess alcohol are both related to all‐cause and liver mortality—the latter with evidence of a supra‐additive interaction between the risk factors. The presence of both factors in the same population and their impact should inform treatment, public health policies and research.
- 8 March 2021
- Published by Wiley in Drug and Alcohol Review
- Vol. 40 (6) , 1061-1070
Impact of body mass and alcohol consumption on all‐cause and liver mortality in 240 000 adults in the United States
Introduction: Nationally representative studies of the combined impact of drinking and body mass (BMI) on mortality outcomes are unavailable. We investigate whether both act together to elevate risk of all‐cause or liver mortality.Methods: We obtained self‐reported histories of drinking and BMI from 129 098 women (mean age 47.2 years) and 102 568 men (mean age 45.6 years) ≥18 years interviewed from 1997 to 2004 in the National Health Interview Survey and related these data to the deaths that occurred by 31 December 2006 (women = 8486; men = 7819 deaths). Death hazards among current drinkers in different BMI groups were adjusted for age, education, race and smoking.Results: Obese (≥30 kg m−2) adults with consumption of >40 g day−1 (women) or >60 g day−1 (men) pure ethanol were at risk of increased mortality from all‐cause and chronic liver disease (P trend −2, each 5 kg m−2 higher BMI was associated with an elevated all‐cause mortality in men (hazard ratios 1.27, 95% confidence interval [CI]: 1.16–1.40) and women (1.12, [1.02–1.24]). The excess risk due to interaction was more pronounced in men (7.30, [3.60–11.00]) than women (2.90, [0.50–5.30]).Discussion and Conclusions: Obesity and excess alcohol are both related to all‐cause and liver mortality—the latter with evidence of a supra‐additive interaction between the risk factors. The presence of both factors in the same population and their impact should inform treatment, public health policies and research.
- Open Access
- 18 May 2012
- Published by Springer Nature in Population Health Metrics
- Vol. 10 (1) , 9
Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption
Alcohol consumption is a major risk factor for injuries; however, international data on this burden are limited. This article presents new methods to quantify the burden of injuries attributable to alcohol consumption and quantifies the number of deaths, potential years of life lost (PYLL), and disability-adjusted life years (DALYs) lost from injuries attributable to alcohol consumption for 2004. Data on drinking indicators were obtained from the Comparative Risk Assessment study. Data on mortality, PYLL, and DALYs for injuries were obtained from the World Health Organization. Alcohol-attributable fractions were calculated based on a new risk modeling methodology, which accounts for average and heavy drinking occasions. 95% confidence intervals (CIs) were calculated using a Monte Carlo simulation method. In 2004, 851,900 (95% CI: 419,400 to 1,282,500) deaths, 19,051,000 (95% CI: 9,767,000 to 28,243,000) PYLL, and 21,688,000 (95% CI: 11,097,000 to 32,385,000) DALYs for people 15 years and older were due to injuries attributable to alcohol consumption. With respect to the total number of deaths, harms to others were responsible for 15.1% of alcohol-attributable injury deaths, 14.5% of alcohol-attributable injury PYLL, and 11.35% of alcohol-attributable injury DALYs. The overall burden of injuries attributable to alcohol consumption corresponds to 17.3% of all injury deaths, 16.7% of all PYLL, and 13.6% of all DALYs caused by injuries, or 1.4% of all deaths, 2.0% of all PYLL, and 1.4% of all DALYs in 2004. The novel methodology described in this article to calculate the burden of injuries attributable to alcohol consumption improves on previous methodology by more accurately calculating the burden of injuries attributable to one's own drinking, and for the first time, calculates the burden of injuries attributable to the alcohol consumption of others. The burden of injuries attributable to alcohol consumption is large and is entirely avoidable, and policies and strategies to reduce it are recommended.
- 18 May 2012
- Published by Springer Nature in Population Health Metrics
- Vol. 10 (1) , 9
Open AccessGlobal burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption
Alcohol consumption is a major risk factor for injuries; however, international data on this burden are limited. This article presents new methods to quantify the burden of injuries attributable to alcohol consumption and quantifies the number of deaths, potential years of life lost (PYLL), and disability-adjusted life years (DALYs) lost from injuries attributable to alcohol consumption for 2004. Data on drinking indicators were obtained from the Comparative Risk Assessment study. Data on mortality, PYLL, and DALYs for injuries were obtained from the World Health Organization. Alcohol-attributable fractions were calculated based on a new risk modeling methodology, which accounts for average and heavy drinking occasions. 95% confidence intervals (CIs) were calculated using a Monte Carlo simulation method. In 2004, 851,900 (95% CI: 419,400 to 1,282,500) deaths, 19,051,000 (95% CI: 9,767,000 to 28,243,000) PYLL, and 21,688,000 (95% CI: 11,097,000 to 32,385,000) DALYs for people 15 years and older were due to injuries attributable to alcohol consumption. With respect to the total number of deaths, harms to others were responsible for 15.1% of alcohol-attributable injury deaths, 14.5% of alcohol-attributable injury PYLL, and 11.35% of alcohol-attributable injury DALYs. The overall burden of injuries attributable to alcohol consumption corresponds to 17.3% of all injury deaths, 16.7% of all PYLL, and 13.6% of all DALYs caused by injuries, or 1.4% of all deaths, 2.0% of all PYLL, and 1.4% of all DALYs in 2004. The novel methodology described in this article to calculate the burden of injuries attributable to alcohol consumption improves on previous methodology by more accurately calculating the burden of injuries attributable to one's own drinking, and for the first time, calculates the burden of injuries attributable to the alcohol consumption of others. The burden of injuries attributable to alcohol consumption is large and is entirely avoidable, and policies and strategies to reduce it are recommended.
- Open Access
- 31 January 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 91
Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005
Alcohol is a substantial risk factor for mortality according to the recent 2010 World Health Assembly strategy to reduce the harmful use of alcohol which outlined the need to characterize and monitor this burden. Accordingly, using new methodology we estimated 1) the number of deaths caused and prevented by alcohol consumption, and 2) the potential years of life lost (PYLLs) attributable to alcohol consumption in Canada in 2005.
- 31 January 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 91
Open AccessMortality and potential years of life lost attributable to alcohol consumption in Canada in 2005
Alcohol is a substantial risk factor for mortality according to the recent 2010 World Health Assembly strategy to reduce the harmful use of alcohol which outlined the need to characterize and monitor this burden. Accordingly, using new methodology we estimated 1) the number of deaths caused and prevented by alcohol consumption, and 2) the potential years of life lost (PYLLs) attributable to alcohol consumption in Canada in 2005.
- Open Access
- 16 August 2011
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 8 (8) , 3351-3364
A Literature Review of Cost-Benefit Analyses for the Treatment of Alcohol Dependence
The purpose of this study was to conduct a literature review of cost-benefit studies on pharmacotherapy and psychotherapy treatments of alcohol dependence (AD). A literature search was performed in multiple electronic bibliographic databases. The search identified seven psychotherapy studies from the USA and two pharmacotherapy studies from Europe. In the psychotherapy studies, major benefits are typically seen within the first six months of treatment. The benefit-cost ratio ranged from 1.89 to 39.0. Treatment with acamprosate was found to accrue a net benefit of 21,301 BEF (528 €) per patient over a 24-month period in Belgium and lifetime benefit for each patient in Spain was estimated to be Pta. 3,914,680 (23,528 €). To date, only a few studies exist that have examined the cost-benefit of psychotherapy or pharmacotherapy treatment of AD. Most of the available treatment options for AD appear to produce marked economic benefits.
- 16 August 2011
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 8 (8) , 3351-3364
Open AccessA Literature Review of Cost-Benefit Analyses for the Treatment of Alcohol Dependence
The purpose of this study was to conduct a literature review of cost-benefit studies on pharmacotherapy and psychotherapy treatments of alcohol dependence (AD). A literature search was performed in multiple electronic bibliographic databases. The search identified seven psychotherapy studies from the USA and two pharmacotherapy studies from Europe. In the psychotherapy studies, major benefits are typically seen within the first six months of treatment. The benefit-cost ratio ranged from 1.89 to 39.0. Treatment with acamprosate was found to accrue a net benefit of 21,301 BEF (528 €) per patient over a 24-month period in Belgium and lifetime benefit for each patient in Spain was estimated to be Pta. 3,914,680 (23,528 €). To date, only a few studies exist that have examined the cost-benefit of psychotherapy or pharmacotherapy treatment of AD. Most of the available treatment options for AD appear to produce marked economic benefits.
- Top Cited PapersOpen Access
- 6 July 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (12) , 1411-1421
Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses
Please cite this paper as: Patra J, Bakker R, Irving H, Jaddoe V, Malini S, Rehm J. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses. BJOG2011;118:1411–1421.Background Descriptions of the effects of moderate alcohol consumption during pregnancy on adverse pregnancy outcomes have been inconsistent.Objective To review systematically and perform meta‐analyses on the effect of maternal alcohol exposure on the risk of low birthweight, preterm birth and small for gestational age (SGA).Search strategy Using Medical Subject Headings, a literature search of MEDLINE, EMBASE, CINAHL, CABS, WHOlist, SIGLE, ETOH, and Web of Science between 1 January 1980 and 1 August 2009 was performed followed by manual searches.Selection criteria Case–control or cohort studies were assessed for quality (STROBE), 36 available studies were included.Data collection and analysis Two reviewers independently extracted the information on low birthweight, preterm birth and SGA using a standardised protocol. Meta‐analyses on dose–response relationships were performed using linear as well as first‐order and second‐order fractional polynomial regressions to estimate best fitting curves to the data.Main results Compared with abstainers, the overall dose–response relationships for low birthweight and SGA showed no effect up to 10 g pure alcohol/day (an average of about 1 drink/day) and preterm birth showed no effect up to 18 g pure alcohol/day (an average of 1.5 drinks/day); thereafter, the relationship showed a monotonically increasing risk for increasing maternal alcohol consumption. Moderate consumption during pre‐pregnancy was associated with reduced risks for all outcomes.Conclusions Dose–response relationship indicates that heavy alcohol consumption during pregnancy increases the risks of all three outcomes whereas light to moderate alcohol consumption shows no effect. Preventive measures during antenatal consultations should be initiated.
- 6 July 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (12) , 1411-1421
Top Cited PapersOpen AccessDose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses
Please cite this paper as: Patra J, Bakker R, Irving H, Jaddoe V, Malini S, Rehm J. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses. BJOG2011;118:1411–1421.Background Descriptions of the effects of moderate alcohol consumption during pregnancy on adverse pregnancy outcomes have been inconsistent.Objective To review systematically and perform meta‐analyses on the effect of maternal alcohol exposure on the risk of low birthweight, preterm birth and small for gestational age (SGA).Search strategy Using Medical Subject Headings, a literature search of MEDLINE, EMBASE, CINAHL, CABS, WHOlist, SIGLE, ETOH, and Web of Science between 1 January 1980 and 1 August 2009 was performed followed by manual searches.Selection criteria Case–control or cohort studies were assessed for quality (STROBE), 36 available studies were included.Data collection and analysis Two reviewers independently extracted the information on low birthweight, preterm birth and SGA using a standardised protocol. Meta‐analyses on dose–response relationships were performed using linear as well as first‐order and second‐order fractional polynomial regressions to estimate best fitting curves to the data.Main results Compared with abstainers, the overall dose–response relationships for low birthweight and SGA showed no effect up to 10 g pure alcohol/day (an average of about 1 drink/day) and preterm birth showed no effect up to 18 g pure alcohol/day (an average of 1.5 drinks/day); thereafter, the relationship showed a monotonically increasing risk for increasing maternal alcohol consumption. Moderate consumption during pre‐pregnancy was associated with reduced risks for all outcomes.Conclusions Dose–response relationship indicates that heavy alcohol consumption during pregnancy increases the risks of all three outcomes whereas light to moderate alcohol consumption shows no effect. Preventive measures during antenatal consultations should be initiated.
- 31 March 2011
- Published by Elsevier in International Journal of Drug Policy
- Vol. 22 (2) , 109-119
Avoidable alcohol-attributable criminality and its costs due to selected interventions in Canada
- 31 March 2011
- Published by Elsevier in International Journal of Drug Policy
- Vol. 22 (2) , 109-119
Avoidable alcohol-attributable criminality and its costs due to selected interventions in Canada